Bone marrow dose from radiation treatment of cancer bladder

In this study the active marrow dose is calculated and measured for patients treated from cancer. Bladder represents the highest incidence among the other cancers in Egypt [21%] and where the pelvic region contains about 40% of the total active bone marrow in human body of age 40 years. Thermoluminescent dosimeters were used to measure the active marrow dose from two different techniques usually used in treating cancer bladder

Optimization of radiation therapy using thermoluminescence dosimeter

The physical characters of lithium fluoric LIF [100] dosimeters were studied and used to measure the effect of the internal anatomical structure on the depth dose distribution in the pelvic region. The measurements were carried out on a humanoid system subjected to irradiation from telecobalt-60 machine. Two irradiation techniques were used, the box and the three field arrangements. The experiment aimed to measure and calculate the target dose distribution